Secretory expression of p53(N15)-Ant following lentivirus-mediated gene transfer induces cell death in human cancer cells

Cancer Investigation

Volumn 26, Issue 1, 2008, Pages 28-34

  Li, Yueping ^a   Qiu, Shudong ^a   Song, Liping ^b   Yan, Qingfeng ^c   Yang, Guangxiao ^d  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c HAINAN MEDICAL UNIVERSITY   (China)

^d Xi'an Huaguang Biological Engineering Co Ltd   (China)

Author keywords

Cancer gene therapy; P53; Recombinant lentivirus; Secretory expression

Indexed keywords

HELIX LOOP HELIX PROTEIN; LENTIVIRUS VECTOR; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CELL DEATH; CELL MEMBRANE; CELL STRAIN HEPG2; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; MUTANT; NULL CELL; PRIORITY JOURNAL; PROTEIN STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; WILD TYPE;

CELL DEATH; CELL LINE, TUMOR; FLOW CYTOMETRY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, P53; GENETIC VECTORS; HUMANS; LENTIVIRUS; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASMS;

EID: 37849010951     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701681384     Document Type: Article

References (20)

1. Balint, E.E.; Vousden, K.H. Activation and activities of the p53 tumor suppressor protein. Br. J. Cancer 2001, 85, 1813-1823.
2. Boyd, S.D.; Tsai, K.Y.; Jacks, T. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat. Cell. Biol. 2000, 2, 563-568.
3. Fang, S.; Jensen, J.P.; Ludwig, R.L.; Vousden, K.H.; Weissman, A.M. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 2000, 275(12), 8945-8951.
4. Honda, R.; Yasuda, H. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase. Oncogene 2000, 19(11), 1473-1476.
5. Haupt, Y.; Maya, R.; Kazaz, A.; Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387(6630), 296-299.
6. Kubbutat, M.H.; Jones, S.N.; Vousden, K.H. Regulation of p53 stability by Mdm2. Nature 1997, 387(6630), 299-303.
7. Lain, S. Protecting p53 from degradation. Biochem Soc Trans. 2003, 31(3), 482-485.
8. Kanovsky, M.; Raffo, A.; Drew, L.; Rosal, R.. Peptides from the amino terminal mdm2-binding domin of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells. Proc Natl Acad Sci U S A. 2001, 98 (22)1, 2438-12443.
9. Do, T.N.; Rosal, R.V.; Drew, L.; Raffo, A.J. Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site. Oncogene. 2003, 22(10), 1431-1444.
10. Hua, Z.; Haitao, H.; Huimin R. The cloning of the human neurotrophin 4 gene. J Xi'an Med Univ. (Engl. Ed.) 2001, 13(2) 172-176. Chinese
11. Guoxi, Z.; Yu, Y.; Hongliang, Z.; Quanying, W.; Guangxiao, Y. Construction of expression vector for NT4 (Si)-ADNF fusion gene. J. Xi'an Jiaotong University (Medical Sciences). 2003, 24(5), 427-430. Chinese
12. Smith, D.J.; Leil, T.A.; Liu, X. Neurotrophin-4 is required for tolerance to morphine in the mouse. Neurosci Lett. 2003, 340(2), 103-106
13. Timmusk, T.; Belluardo, N.; Metsis, M.; Persson, H. Widespread and developmentally regulated expression of neurotrophin-4 mRNA in rat brain and peripheral tissues. Eur J Neurosci. 1993, 5(6), 605-613.
14. Ip, N.Y.; Ibanez, C.F.; Nye, S.H.; McClain, J. Mammalian neurotrophin -4:structure, chromosomal localization, tissue distribution receptor specificity. Proc. Natl. Acad. Sci. USA 1997, 89(7), 3060-3064
15. Yu, Y.; Jiang, W.; Xin, Y.; Senglin, H. The construction of NT4 (Si)-NAP fusion gene vector and its expression in Ecoli. Journal of Neurology. 2004, 37(3), 260-261. Chinese
16. Lever, A.M.; Strappe, P.M.; Zhao, J. Lentiviral vectors. J. Biomed. Sci. 2004, 11(4), 439-49.
17. Naldini, L.; Blomer, U.; Gallay, P.; Ory, D.; Mulligan, R. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996, 272(5259), 263-267.
18. Dull, T.; Zufferey, R.; Kelly, M.; Mandel, R.J. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 1998, 72(11), 8463-8471.
19. Zufferey, R.; Nagy, D.; Mandel, R.J.; Naldini, L. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 1997, 15(9), 871-875
20. Rosal, R.; Brandt-Rauf, P.; Pincus, M.R.; Wang, H. The role of alpha-helical structure in p53 peptides as a determinant for their mechanism of cell death: necrosis versus apoptosiss. Adv. Drug Deliv. Rev. 2005, 57(4), 653-660.